Database
As part of its curating function, the Global Observatory collects, summarizes, and sorts resources relevant to the ethics and governance of emerging biotechnologies. Use the “Search and Filter” box on the left side of the page to navigate the resources in this database.
Search and Filter
2005
Sheila Jasanoff
In this seminal book, Observatory Director Sheila Jasanoff explains the reasons behind the different paths that the US, the UK, and Germany have taken in biotechnology policy and regulation.
2005
David Winickoff , Sheila Jasanoff , Lawrence Busch , Robin Grove-White
Agricultural biotechnology | International | Law | Moratoria | Observatory author | Regulation | Scholarly
This piece was originally written by four scholars, including Observatory Director Sheila Jasanoff, as an amicus curiae brief to the World Trade Organization (WTO).
2003-02
Inder M. Verma
In this brief piece, then-Editor-in-Chief of Molecular Therapy draws on the occurrence of multiple adverse events in clinical trials of retrovirus-mediated gene therapies to address the question of whether a voluntary moratorium is necessary.
2001-08
LeRoy Walters
LeRoy Walters, Georgetown bioethicist and one of the authors of the report of the Ethics Advisory Board report on in vitro fertilization (IVF), reflects on the trajectory that federal policy on human embryo followed in the decades after the report’s publication.
1998-01
Fritz H. Bach , Harvey V. Fineberg
Two Harvard University researchers call for a moratorium on clinical trials of xenotransplantation in a brief Nature commentary. They specifically invoke the precedent of Asilomar as a “turning point” for scientists’ approach to public responsibility.